Life sciences professionals will need to keep up with market demand for biologics and biosimilars.
Sotirios Stergiopoulos
Advertisement
Articles by Sotirios Stergiopoulos
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
3
How Have Recent Regulatory Actions Impacted the Rare Disease Space?
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5